What is PF-05180999 used for?

PF-05180999 is being studied for the treatment of schizophrenia and migraine disorders.

Is PF-05180999 an approved medicine?

No, PF-05180999 is currently in the research phase (max phase 1) and is not yet an approved drug.

It is classified as a small molecule drug.

Research is looking into whether PF-05180999 can be used for migraine disorders.

PF-05180999 is being investigated as a potential treatment for schizophrenia.

It is currently in phase 1 of development.

Loading compound...

Small molecule experimental drug

PF-05180999 is an experimental small molecule drug currently being studied for its potential to treat schizophrenia and migraine disorders.

How it worksThis drug is a small molecule designed to interact with specific biological targets to address neurological conditions.

Used for

SchizophreniaMigraine disorders

Conditions

SchizophreniaMigraine disorder

Class

Small moleculeSmall molecule experimental drugNervous system

This is an investigational compound and is not yet approved for general use.

Questions to ask

Educational summary derived from FDA labeling, AI-assisted. Not medical advice — consult a healthcare professional. Updated 2026-04-25.